Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Randomized, Multicenter, Allopurinol and Placebo-Controlled Study Assessing the Safety and Efficacy of Oral Febuxostat in Subjects With Gout.

NCT00174915 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT00174915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00174915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Randomized, Multicenter, Allopurinol and Placebo-Controlled Study Assessing the Safety and Efficacy of Oral Febuxostat in Subjects With Gout.
Lead sponsor
Takeda
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2003
Completion date
April 30, 2004
Enrollment
1,072 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gout